Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PAB - Patrys secures US patents for antibody technology

PAB - Patrys secures US patents for antibody technology

PGIM Active Aggregate Bond ETF

(NewsDirect)

Patrys Ltd (ASX:PAB) managing director and CEO Dr James Campbelltalks with Proactive’s Elisha Newell about two new patents thatadvance protection for the company’s antibody technology through to2039. The first patent, co-filed with Yale University, is the first USpatent to be granted specifically for PAT-DX1 and PAT-DX3, while thesecond covers deoxymabs with nanocarriers — a combination that couldprovide a powerful new approach for treating cancer. Dr Campbellhighlights the growing opportunity in the cancer therapeutics spaceand says Patrys looks forward to its first-in-human clinical trial forPAT-DX1 next year.

ContactDetails

Proactive Investors

JonathanJackson

+61 413 713 744

jonathan@proactiveinvestors.com

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information
Company Name: PGIM Active Aggregate Bond ETF
Stock Symbol: PAB
Market: NYSE
Menu
PAB PAB Quote PAB Short PAB News PAB Articles PAB Message Board
Get PAB Alerts

News, Short Squeeze, Breakout and More Instantly...